This website is intended for healthcare professionals only

Tolvaptan (Jinarc®▼) 15mg, 30mg, 45mg, 60mg and 90mg tablets SMC No. (1114/15)

Disclaimer: Information intended for healthcare professionals only. This Guidelines card, which summarises Scottish Medicines Consortium (SMC) advice on tolvaptan, has been initiated by Otsuka Pharmaceutical (UK) Ltd. Otsuka Pharmaceutical (UK) Ltd has reviewed this card for technical accuracy and regulatory compliance. Otsuka Pharmaceutical (UK) Ltd has provided the supplementary information and prescribing information overleaf. The SMC has reviewed this card for technical accuracy and permission request only. The SMC was not involved in the production of this card.



COPD diagnosis, management and prevention
Global Initiative for Chronic Obstructive Lung Disease

Choosing an appropriate inhaler device for the treatment of adults with asthma or COPD
Development Group: Usmani, Capstick, Chowhan, & Scullion.
This management algorithm was developed by a multidisciplinary expert panel: Usmani et al with the support of a grant from Chiesi Ltd.

Summary of the management of asthma in children (from the British guideline on the management of asthma)
The British Thoracic Society & Scottish Intercollegiate Guidelines Network

Summary of the management of asthma in adults (from the British guideline on the management of asthma)
The British Thoracic Society & Scottish Intercollegiate Guidelines Network

Rosacea—primary care treatment pathway
Primary Care Dermatology Society

Choosing an appropriate inhaler device for the treatment of adults with asthma or COPD
Development Group: Usmani, Capstick, Chowhan, & Scullion.
This management algorithm was developed by a multidisciplinary expert panel: Usmani et al with the support of a grant from Chiesi Ltd.

COPD diagnosis, management and prevention
Global Initiative for Chronic Obstructive Lung Disease



Visit our NEW site!

Guidelines for Nurses provides current, credible summaries and feature articles developed especially for nurses.